Mahyar Etminan, an epidemiologist at the University of British Columbia and senior author of the study, said up to two per cent of patients who used semaglutide and liraglutide medications to lose weight developed gastrointestinal problems
That way, you can avoid burnout and over-exercising
Beyond their metabolic benefits, GLP-1 RAs exhibit neuroprotective and psychotropic effects, potentially benefiting mental health conditions like depression and anxiety
Recalls & Warnings May 11, 2006 Weight-Loss Marketers Pay $3 Million for Deceptive Advertising On May 11, the Federal Trade Commission (FTC) announced that sellers making questionable weight-loss and fat-loss claims to peddle skin gels and diet supplements will pay $3 million to settle charges that their deceptive claims violated federal law
True, sustainable weight management requires a deeper, more targeted approach that addresses metabolism and appetite at their core